MRO Magazine

Xylem Inc. reports solid first quarter earnings

April 30, 2015 | By Business Wire News


Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today reported first quarter 2015 net income of $64 million, or $0.35 per share. Excluding the gain from the sale of businesses, restructuring and realignment charges and other special items, adjusted net income was $60 million or $0.33 per share, a decrease of one cent or three percent from the comparable period in 2014. First quarter revenue was $837 million, up one percent organically, reflecting strength in emerging markets and the U.S. First quarter adjusted operating margin improved 40 basis points, driven by increased operating efficiencies and lower expenses.

“We are off to a solid start in 2015 as we continue to advance our strategy,” said Patrick Decker, President and Chief Executive Officer of Xylem. “We saw continued strength in emerging markets and growing momentum in the U.S. Our Water Infrastructure segment generated solid growth in orders during the quarter, including double-digit growth in treatment orders. A great example is the $16 million order we secured to upgrade the drinking water treatment plants and distribution systems of a Canadian municipality.”

Decker continued, “Despite the ongoing negative impact of foreign exchange translation, the fundamentals of our core business continue to improve. This was evident in our ability to drive a nine-percent increase in year-over-year adjusted earnings per share in the first quarter, excluding these foreign exchange headwinds. Looking ahead, we will focus on accelerating operational improvements as we continue to strengthen key capabilities in the organization.”

During the first quarter 2015, Xylem repurchased 1.4 million shares of common stock under its stock repurchase program for an aggregate purchase price of $50 million. As of March 31, 2015, Xylem had approximately $50 million remaining under its current stock repurchase authorizations.

Full-year 2015 Outlook

Xylem is maintaining its operational outlook for its full-year guidance. The Company, however, is adjusting its 2015 guidance to reflect the significant foreign exchange fluctuations that have occurred since the Company’s previous forecast was announced in February. As a result of the projected unfavorable impact of foreign exchange translation, Xylem now expects full-year 2015 revenue of approximately $3.7 billion, a decrease of seven to eight percent from the full-year 2014 results. On an organic basis, Xylem continues to anticipate revenue growth in the range of one to three percent.

Full-year 2015 adjusted operating income is now expected to be in the range of $469 to $494 million, resulting in adjusted earnings per share of $1.80 to $1.90. Excluding the projected unfavorable impact of foreign exchange translation, Xylem’s adjusted earnings per share growth expectations remain unchanged in the range of five to 10 percent over the comparable full-year 2014 results. The Company’s outlook for projected restructuring and realignment costs of $20 million for the year also remains unchanged.

First Quarter Segment Results

Water Infrastructure

Xylem’s Water Infrastructure segment consists of its businesses serving clean water delivery, wastewater transport and treatment, dewatering and analytical instrumentation.

  • First quarter 2015 Water Infrastructure revenue was $500 million, flat relative to the prior year period on an organic basis. Growth in emerging markets was driven by continued investment in the development of water and wastewater infrastructure, which was offset by the timing of prior-year project deliveries in Australia as well as market softness there and in Canada.
  • First quarter adjusted segment operating income was $53 million, down from $58 million in the prior year, reflecting the unfavorable impact of foreign exchange translation. Adjusted operating margin for the quarter increased 10 basis points to 10.6 percent, primarily driven by the impact of cost reductions, which was partially offset by inflation.

Applied Water

Xylem’s Applied Water segment consists of its portfolio of businesses in residential and commercial building services, and industrial and agricultural applications.

  • First quarter 2015 revenue was $337 million, up two percent organically compared with the first quarter 2014. This growth was driven by strength in our U.S. commercial building services business, partially offset by the impact of softening markets in agriculture.
  • First quarter adjusted segment operating income was $47 million, flat versus the comparable period last year. The impact of productivity actions and cost reductions helped to drive a 60-basis-point increase in the adjusted operating margin for the segment to 13.9 percent. This margin expansion included the absorption of a 30-basis-point negative impact from foreign exchange translation.

Supplemental information on Xylem’s first quarter earnings and reconciliations for non-GAAP items are posted at

About Xylem

Xylem (XYL) is a leading global water technology provider, enabling customers to transport, treat, test and efficiently use water in public utility, residential and commercial building services, industrial and agricultural settings. The Company does business in more than 150 countries through a number of market-leading product brands, and its people bring broad applications expertise with a strong focus on finding local solutions to the world’s most challenging water and wastewater problems. Xylem is headquartered in Rye Brook, New York, with 2014 revenues of $3.9 billion and approximately 12,500 employees worldwide. Xylem was named to the Dow Jones Sustainability Index for the last three years for advancing sustainable business practices and solutions worldwide.

The name Xylem is derived from classical Greek and is the tissue that transports water in plants, highlighting the engineering efficiency of our water-centric business by linking it with the best water transportation of all – that which occurs in nature. For more information, please visit us at

Forward-Looking Statements

This press release contains information that may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “forecast,” “believe,” “target,” “will,” “could,” “would,” “should” and similar expressions identify forward-looking statements, which generally are not historical in nature. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. These forward-looking statements include statements about the capitalization of the Company, the Company’s restructuring and realignment, future strategic plans and other statements that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals. All statements that address operating or financial performance, events or developments that we expect or anticipate will occur in the future – including statements relating to orders, revenue, operating margins and earnings per share growth, and statements expressing general views about future operating results – are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from those expressed or implied in, or reasonably inferred from, such forward-looking statements.

Factors that could cause results to differ materially from those anticipated include: economic, political and other risks associated with our international operations, including military actions, economic sanctions or trade embargoes that could affect customer markets, and non-compliance with laws, including foreign corrupt practice laws, export and import laws and competition laws; potential for unexpected cancellations or delays of customer orders in our reported backlog; our exposure to fluctuations in foreign currency exchange rates; competition and pricing pressures in the markets we serve; the strength of housing and related markets; weather conditions; ability to retain and attract key members of management; our relationship with and the performance of our channel partners; our ability to borrow or to refinance our existing indebtedness and availability of liquidity sufficient to meet our needs; changes in the value of goodwill or intangible assets; risks relating to product defects, product liability and recalls; governmental investigations; security breaches or other disruptions of our information technology systems; litigation and contingent liabilities; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2014 and with subsequent filings we make with the Securities and Exchange Commission.

All forward-looking statements made herein are based on information available to the Company as of the date of this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.




(in millions, except per share data)

For the three months ended March 31,   2015 2014
Revenue $ 837 $ 906
Cost of revenue 522   564  
Gross profit 315 342
Selling, general and administrative expenses 206 224
Research and development expenses 23 27
Restructuring charges 3   15  
Operating income 83 76
Interest expense 14 14
Other non-operating (expense), net (1 ) (1 )
Gain from sale of businesses 9    
Income before taxes 77 61
Income tax expense 13   12  
Net income $ 64   $ 49  
Earnings per share:
Basic $ 0.35 $ 0.27
Diluted $ 0.35 $ 0.27
Weighted average number of shares:
Basic 182.1 184.5
Diluted 183.1 185.8
Dividends declared per share $ 0.1408 $ 0.1280



(in millions, except per share amounts)


March 31,


December 31,

Current assets:
Cash and cash equivalents $ 554 $ 663

Receivables, less allowances for discounts and doubtful accounts
of $28 and $34 in 2015 and 2014, respectively

738 771
Inventories 502 486
Prepaid and other current assets 141 144
Deferred income tax assets 38   38  
Total current assets 1,973 2,102
Property, plant and equipment, net 434 461
Goodwill 1,582 1,635
Other intangible assets, net 446 470
Other non-current assets 185   192  
Total assets $ 4,620   $ 4,860  
Current liabilities:
Accounts payable $ 311 $ 338
Accrued and other current liabilities 441 481
Short-term borrowings and current maturities of long-term debt 81   89  
Total current liabilities 833 908
Long-term debt 1,195 1,195
Accrued postretirement benefits 374 388
Deferred income tax liabilities 152 158
Other non-current accrued liabilities 77   84  
Total liabilities 2,631   2,733  
Commitments and contingencies (Note 17)
Stockholders’ equity:
Common Stock – par value $0.01 per share:

Authorized 750.0 shares, issued 189.4 shares and 188.9 shares
in 2015 and 2014, respectively

2 2
Capital in excess of par value 1,807 1,796
Retained earnings 686 648

Treasury stock – at cost 8.1 shares and 6.6 shares in 2015 and
2014, respectively

(273 ) (220 )
Accumulated other comprehensive loss (233 ) (99 )
Total stockholders’ equity 1,989   2,127  
Total liabilities and stockholders’ equity $ 4,620   $ 4,860  



(in millions)

For the three months ended March 31,   2015   2014
Operating Activities  
Net income $ 64 $ 49

Adjustments to reconcile net income to net cash provided by
operating activities:

Depreciation 24 23
Amortization 11 13
Share-based compensation 4 4
Restructuring charges 3 15
Gain from sale of businesses (9 )
Other, net 1 4
Payments for restructuring (6 ) (9 )
Changes in assets and liabilities (net of acquisitions):
Changes in receivables 4 (5 )
Changes in inventories (33 ) (42 )
Changes in accounts payable 4 (2 )
Other, net (28 ) (28 )
Net Cash – Operating activities 39   22  
Investing Activities
Capital expenditures (37 ) (25 )
Proceeds from sale of businesses 1
Proceeds from the sale of property, plant and equipment   1  
Net Cash – Investing activities (36 ) (24 )
Financing Activities
Issuance of short-term debt 2
Repurchase of common stock (53 ) (51 )
Proceeds from exercise of employee stock options 6 11
Dividends paid (26 ) (24 )
Other, net 2    
Net Cash – Financing activities (71 ) (62 )
Effect of exchange rate changes on cash (41 ) (3 )
Net change in cash and cash equivalents (109 ) (67 )
Cash and cash equivalents at beginning of year 663   533  
Cash and cash equivalents at end of period $ 554   $ 466  
Supplemental disclosure of cash flow information:
Cash paid during the period for:
Interest $ 11 $ 11
Income taxes (net of refunds received) $ 8 $ 18
Xylem Inc. Non-GAAP Measures
Management views key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, free cash flow, working capital, and backlog, among others. In addition, we consider certain measures to be useful to management and investors evaluating our operating performance for the periods presented, and provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operations as determined in accordance with GAAP. We consider the following non-GAAP measures, which may not be comparable to similarly titled measures reported by other companies, to be key performance indicators:

“Organic revenue” and “Organic orders” defined as revenue and orders, respectively, excluding the impact of foreign currency fluctuations and contributions from acquisitions and divestitures. Divestitures include sales of portions of our business that did not meet the criteria for classification as a discontinued operation or insignificant portions of our business that we did not classify as a discontinued operation. The period-over-period change resulting from foreign currency fluctuations assumes no change in exchange rates from the prior period.

“Constant currency” defined as financial results adjusted for currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar.
“EBITDA” defined as earnings before interest, taxes, depreciation, amortization expense, and share-based compensation. “Adjusted EBITDA” reflects the adjustment to EBITDA to exclude restructuring and realignment costs, gain on sale of business and special charges.
“Adjusted Operating Income”, “Adjusted Segment Operating Income”, and “Adjusted EPS” defined as operating income, segment operating income and earnings per share, adjusted to exclude restructuring and realignment costs, gain on sale of businesses, special charges and tax-related special items, as applicable.
“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flow, less capital expenditures as well as adjustments for other significant items that impact current results which management believes are not related to our ongoing operations and performance. Our definition of free cash flows does not consider non-discretionary cash payments, such as debt.
“Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.
“Special charges” defined as costs incurred by the Company, such as legal and professional fees, associated with the Korea matters, as well as costs incurred for the contractual indemnification of tax obligations to ITT.
Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Order Growth
($ Millions)
(As Reported – GAAP) (As Adjusted – Organic)


  (A)   (B)   (C)   (D)   (E) = B+C+D   (F) = E/A (G) = (E – C) / A
Change % Change


Change % Change
Orders Orders

2015 v.

2015 v.


FX Contribution

Adj. 2015
v. 2014

Adj. 2015
v. 2014

2015 2014

Quarter Ended March 31

Xylem Inc. 915 993 (78) -8% 5 77 4 0% 0%
Water infrastructure 562 597 (35) -6% 56 21 4% 4%
Applied Water 353 396 (43) -11% 5 21 (17) -4% -6%
Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Revenue
($ Millions)
(As Reported – GAAP) (As Adjusted – Organic)


  (A)   (B)   (C)   (D)   (E) = B+C+D   (F) = E/A (G) = (E – C) / A
Change % Change


Change % Change
Revenue Revenue

2015 v.

2015 v.


FX Contribution

Adj. 2015
v. 2014

Adj. 2015
v. 2014

2015 2014

Quarter Ended March 31

Xylem Inc. 837 906 (69) -8% 5 73 9 1% 0%
Water infrastructure 500 552 (52) -9% 54 2 0% 0%
Applied Water 337 354 (17) -5% 5 19 7 2% 1%
Xylem Inc. Non-GAAP Reconciliation
Adjusted Operating Income
($ Millions)




Total Revenue
• Total Xylem 837 906
• Water Infrastructure 500 552
• Applied Water 337 354
Operating Income
• Total Xylem 83 76
• Water Infrastructure 47 46
• Applied Water 46 41
• Total Segments 93 87
Operating Margin
• Total Xylem 9.9% 8.4%
• Water Infrastructure 9.4% 8.3%
• Applied Water 13.6% 11.6%
• Total Segments 11.1%   9.6%
Special Charges
• Total Xylem 1
• Water Infrastructure 1
• Applied Water
• Total Segments 1
Restructuring & Realignment Costs
• Total Xylem 6 18
• Water Infrastructure 5 12
• Applied Water 1 6
• Total Segments 6 18
Adjusted Operating Income*
• Total Xylem 90 94
• Water Infrastructure 53 58
• Applied Water 47 47
• Total Segments 100 105
Adjusted Operating Margin*
• Total Xylem 10.8% 10.4%
• Water Infrastructure 10.6% 10.5%
• Applied Water 13.9% 13.3%
• Total Segments 11.9%   11.6%

*Adjusted Operating Income excludes restructuring &
realignment costs and special charges.


Xylem Inc. Non-GAAP Reconciliation

Adjusted Diluted EPS

($ Millions, except per share amounts)


Q1 2014

Q1 2015
As Reported   Adjustments   Adjusted As Reported   Adjustments   Adjusted
Total Revenue 906 906 837 837
Operating Income 76 18 a 94 83 7 a 90
Operating Margin 8.4% 10.4% 9.9% 10.8%
Interest Expense (14) (14) (14) (14)
Other Non-Operating Income (Expense) (1) (1) (1) 1 b
Gain from sale of businesses   9 (9) 0
Income before Taxes 61 18 79 77 (1) 76
Provision for Income Taxes (12) (4) c (16) (13) (3) c (16)
Net Income 49 14 63 64 (4) 60
Diluted Shares   185.8         185.8     183.1         183.1
Diluted EPS   $ 0.27   $ 0.07     $ 0.34     $ 0.35   $ (0.02)     $ 0.33
Currency translation impact on current year diluted EPS                   $ (0.04)         $ (0.04)
Diluted EPS at Constant Currency                   $ 0.39         $ 0.37
a   Restructuring & realignment costs in 2014 and 2015 and special charges in 2015
b Special charges
c Net tax impact of restructuring & realignment costs and special charges, and special tax items
Xylem Inc. Non-GAAP Reconciliation
Net Cash – Operating Activities vs. Free Cash Flow
($ Millions)
  Three Months Ended
2015   2014
Net Cash – Operating Activities $ 39 $ 22
Capital Expenditures (37) (25)
Free Cash Flow $ 2 $ (3)
Net Income 64 49
Gain from sale of businesses   9  
Net Income, excluding gain on sale of businesses $ 55 $ 49
Free Cash Flow Conversion   4%   -6%

Xylem Inc.
Kelly McAndrew +1 (914) 323-5969
Phil DeSousa +1 (914) 323-5930


Stories continue below

Print this page